Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 26 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07717242
- Conditions
- Bladder Cancer, Bladder Urothelial Carcinoma, Carcinoma, +14 more
- Locations
-
- Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
Recruiting
Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
NCT07029256
- Conditions
- Bladder Urothelial Carcinoma
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT06263153
- Conditions
- Bladder Urothelial Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
- Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT05296564
- Conditions
- Adnexal Diseases, Bladder Urothelial Carcinoma, Breast Diseases, +54 more
- Locations
-
- Hadassah Medical Organization Jerusalem, Israel
NCT04574960
- Conditions
- Bladder Cancer, Bladder Urothelial Carcinoma, Female Urogenital Diseases, +10 more
- Locations
-
- The Ottawa Hospital Ottawa, Ontario, Canada
- University Health Network Toronto, Ontario, Canada
Recruiting
Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy
NCT06170177
- Conditions
- Bladder Cancer, Bladder Cancer Stage II, Bladder Cancer Stage IIIa, +29 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, MI, Italy
NCT06167356
- Conditions
- Bladder Cancer, Bladder Cancer Recurrent, Bladder Cancer Stage I, With Cancer in Situ, +22 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, MI, Italy
Enrolling by Invitation
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
NCT07353294
- Conditions
- Bladder Urothelial Carcinoma, Lymph Node Metastasis, Lymphatic Metastasis, +5 more
- Locations
-
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
Not Yet Recruiting
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
NCT07414992
- Conditions
- Bladder Urothelial Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
Not Yet Recruiting
Survival Benefits of Neoadjuvant Systemic Chemotherapy in Muscle Invasive Bladder Cancer
NCT06727214
- Conditions
- Bladder Urothelial Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
Not specified
Not Yet Recruiting
ALDOA Expression in Bladder Urothelial Carcinoma
NCT06550947
- Conditions
- Bladder Urothelial Carcinoma
- Locations
-
Not specified
Not Yet Recruiting
Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer
NCT06528483
- Conditions
- Bladder Cancer, Bladder Neoplasm, Bladder Urothelial Carcinoma, +12 more
- Locations
-
- Fondazione Irccs Istituto Nazionale Dei Tumori Di Milano Milan, Italy
NCT02989064
- Conditions
- Bladder Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +20 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Washington University - School of Medicine St Louis, Missouri, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Ohio State University Wexner Medical Center Columbus, Ohio, United States
Completed
Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy
NCT03039413
- Conditions
- Bladder Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +4 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
NCT04570410
- Conditions
- Bladder Urothelial Carcinoma
- Locations
-
- The first affiliated hospital of Nanjing Medical University Nanjing, Jiangsu, China
NCT05788484
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +64 more
- Locations
-
- George Washington University Cancer Center Washington D.C., District of Columbia, United States
- AdventHealth Celebration Celebration, Florida, United States
- Perlmutter Cancer Center at NYU Langone Health New York, United States
- Providence Cancer Institute Portland, Oregon, United States
Completed
Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer
NCT03473730
- Conditions
- Adenocarcinoma, Bladder Urothelial Carcinoma, Carcinoma, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
NCT03329950
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
- Locations
-
- HonorHealth Research Insititute Scottsdale, Arizona, United States
- Northside Hospital, Inc. Atlanta, Georgia, United States
- Georgia Cancer Center at Augusta University Augusta, Georgia, United States
- Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
NCT04200963
- Conditions
- Advanced Cancer, Advanced Solid Tumor, Bladder Cancer, +35 more
- Locations
-
- Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
- Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
- Rush University Medical Center Chicago, Illinois, United States
- Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
Completed
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
NCT04440943
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +61 more
- Locations
-
- Northside Hospital Atlanta, Georgia, United States
- University of Chicago Chicago, Illinois, United States
- Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
- Duke Cancer Center Durham, North Carolina, United States